Yu Fan
Latest statistics and disclosures from Yu Fan's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Prenetics Global, Aeglea Biotherapeutics, SONX, SGMT, PYXS, and represent 100.00% of Yu Fan's stock portfolio.
- Added to shares of these 3 stocks: Prenetics Global (+$55M), Aeglea Biotherapeutics (+$16M), SONX.
- Started 3 new stock positions in SONX, Prenetics Global, Aeglea Biotherapeutics.
- Reduced shares in these 2 stocks: CRGX (-$19M), CSTL.
- Sold out of its positions in CRGX, CSTL.
- Yu Fan was a net buyer of stock by $52M.
- Yu Fan has $73M in assets under management (AUM), dropping by 263.52%.
- Central Index Key (CIK): 0001668029
Tip: Access up to 7 years of quarterly data
Positions held by Yu Fan consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Yu Fan
Yu Fan holds 5 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Prenetics Global Class A Ord | 75.8 | $55M | NEW | 1.3M | 43.90 |
|
| Aeglea Biotherapeutics | 22.7 | $16M | NEW | 737k | 22.32 |
|
| Sonendo (SONX) | 0.7 | $498k | NEW | 23k | 22.15 |
|
| Sagimet Biosciences Com Ser A (SGMT) | 0.4 | $310k | 57k | 5.42 |
|
|
| Pyxis Oncology Common Stock (PYXS) | 0.4 | $295k | 69k | 4.26 |
|
Past Filings by Yu Fan
SEC 13F filings are viewable for Yu Fan going back to 2020
- Yu Fan 2024 Q1 filed May 15, 2024
- Yu Fan 2023 Q4 filed Feb. 14, 2024
- Yu Fan 2023 Q3 filed Nov. 14, 2023
- Yu Fan 2023 Q2 filed Aug. 14, 2023
- Yu Fan 2023 Q1 filed May 15, 2023
- Yu Fan 2022 Q4 filed Feb. 14, 2023
- Yu Fan 2022 Q3 filed Nov. 14, 2022
- Yu Fan 2022 Q2 filed Aug. 15, 2022
- Yu Fan 2022 Q1 filed May 16, 2022
- Yu Fan 2021 Q4 filed Feb. 14, 2022
- Yu Fan 2021 Q3 filed Nov. 15, 2021
- Yu Fan 2021 Q1 restated filed Sept. 17, 2021
- Yu Fan 2021 Q2 restated filed Sept. 17, 2021
- Yu Fan 2021 Q2 filed Aug. 16, 2021
- Yu Fan 2020 Q4 amended filed May 17, 2021
- Yu Fan 2021 Q1 filed May 17, 2021